Stay updated with breaking news from Benjamin Winograd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UTRECT, The Netherlands and PHILADELPHIA, Feb. 06, 2023 -- LAVA Therapeutics N.V. , an immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific... | February 6, 2023
Seagen and LAVA Therapeutics inked a licensing deal for LAVA's Gammabody platform for solid tumors, which can potentially exceed $700 million.
13.09.2022 - Initial Phase 1/2a clinical findings for LAVA-051 in patients with chronic lymphocytic leukemia and multiple myeloma patients demonstrated encouraging anti-tumor activity and safety profile; on track to report additional clinical data in fourth ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
16.06.2022 - Clinical update call featuring LAVA-051 investigator Dr. Arnon Kater and Company management summarized initial Phase 1/2a clinical trial data presented at 2022 ASCO and EHA meetingsUTRECHT, The Netherlands and PHILADELPHIA, June 16, 2022 (GLOBE ... Seite 1